MedPath

Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban in patients with acute pulmonary embolism in showa university

Not Applicable
Conditions
Acute pulmonary embolism
Registration Number
JPRN-UMIN000020069
Lead Sponsor
Division of Cardiology, Department of Medicine,Showa university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

CrCL less than 30ml/min Patients with acute bleeding Patients with active malignancy Patients needed PCPS,IABP and aortic sheathes Contraindication of each drug

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath